ObsEva's endometriosis win puts it back in investors' good graces; Cytokinetics says early SMA treatment shows promise; AMAG divests Cord Blood Registry for $530M; Prescribed Reading: J&J sells off units; another Alzheimer's defeat
Join Bracket, CluePoints, and hundreds of your closest pharma friends in Boston for wholesome fun at The Grand nightclub on Tuesday, June 26, at 10pm.
RSVP now!
With rising pressures to make production more efficient, continuous manufacturing is one way to reduce costs, accelerate production and enhance quality. Pall Biotech, together with The Medicine Maker, has explored the question "Why take the continuous route?" in a new ebook. Get tips for establishing a continuous bioprocessing platform and more. Download the ebook today
Our mission is to provide busy execs like you with an overview of the BioPharma industry in 60 seconds. BioPharma Dive is a product of Industry Dive. View other Industry Dive publications.
This email is optimized for display on mobile phones. BioPharma Dive is a product of Industry Dive, Inc.. 1575 Eye St NW, 4th Floor, Washington, DC 20005. We value your privacy. We won't share your email address with anyone else without your permission. This message was sent to [email protected] You can unsubscribe or change which newsletters you receive anytime. See our full privacy policy.
